Phase II study of rituximab plus three cycles of CHOP and involved-field radiotheraphy for patients with limited-stage aggressive B-cell lymphoma : Southwest Oncology Group study 0014
収録刊行物
-
- J Clin Oncol.
-
J Clin Oncol. 26 2258-2263, 2008